Israeli medtech: A victim of the bursting of the COVID-19 bubble. (Photo: LALAKA/Shutterstock)
The Israeli medtech sector suffered from the bursting of the COVID-19 bubble, an artificially driven interest in the medical industry that declined as the pandemic waned, according to reporting by Globes.
Israel's domestic troubles and the war have also not helped, and FDA approvals for a range of drugs have only gone so far in pushing up stock values.
The one field where Israel saw gains was medical devices, with companies managing to be bought out for hundreds of millions of dollars.
